Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Author(s): Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
Issue: Sep/Oct 2013 - Volume 17, Number 5
View All Articles in Issue
Page(s): 432-435
Download in electronic PDF format for $75
Abstract: Due to the increasing rate in the demand of extemporaneous formulations, it became necessary to assess the pattern of prescription and preparation in a developing institution. The purpose of this study was to assess the pattern of extemporaneous prescription and preparation in the University of Benin Teaching Hospital, Benin City, Nigeria. Records of prescription and preparation of extemporaneous formulations were assessed retrospectively between 2007 and 2011. Fifty-nine different types of drugs were prescribed with a frequency of 6,882 times during the period. These were indicated for eight classes of systemic disease. Eighteen drugs were indicated for central nervous diseases, followed by 16 drugs for cardiovascular diseases. Of the 18 drugs indicated for central nervous diseases, pyridoxine was the most common. Rifampicin for tuberculosis was the most frequently formulated, followed by spironolactone for cardiovascular disorders. Most preparations were labeled to be used for a maximum of two weeks. They were all liquid preparations packaged in amber-colored bottles. Distilled water was the most common vehicle utilized for trituration; while ascorbic acid syrup was commonly used to bulk the solution and as a sweetening agent. None of the patients reported with any form of pharmaceutical degradation or toxicity within two weeks of expected use. There were reports of spillages due to poor handling. Maximum volume prepared was 75 mL. The study suggests an adequate setup of a quality-control unit in the institution to meet the increasing demand for specific agents. This will enhance an effective healthcare delivery among patients.
Related Keywords:
Nigeria, extemporaneous compounding, quality assurance, quality control, excipients, children
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
|
Sep/Oct 2013
Pg. 432-435
|
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding
Kupiec Thomas C, Okeke Claudia, Allen Loyd V Jr, Denison Clay
|
Jul/Aug 2005
Pg. 300-302
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Quality Assurance and Quality Control, Part 2
Akers Michael J
|
May/Jun 2015
Pg. 215-221
|
Quality Assurance and Quality Control, Part 1
Akers Michael J
|
Mar/Apr 2015
Pg. 121-124
|
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices
Kastango Eric S, Trissel Lawrence A, Bradshaw Brian D
|
Sep/Oct 2003
Pg. 401-416
|
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Zolner William J
|
Jul/Aug 2006
Pg. 281-284
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy
Zolner William J
|
Sep/Oct 2009
Pg. 412-418
|
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS, Odegard RD, Raden J, Haraldsen JT
|
Mar/Apr 2014
Pg. 162-168
|
Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 477-480
|
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S, Thyangarajapuram N
|
Sep/Oct 2003
Pg. 389-393
|
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care?
Cabaleiro Joe
|
Jul/Aug 2009
Pg. 318-320
|
Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 481-484
|
Quality Assurance: Compounding Record Audits for Error Prevention
Hawkins Jessica
|
May/Jun 2023
Pg. 211-217
|
Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry?
Dillon L Rad
|
Nov/Dec 2014
Pg. 475-477
|
A Process Verification Model for Quality Assurance in a Compounding Pharmacy
Zolner William J
|
May/Jun 2008
Pg. 247-251
|
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 123-130
|
Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations
Ashworth Lisa D
|
May/Jun 2007
Pg. 226-229
|
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Trusley Craig
|
Nov/Dec 2007
Pg. 487-490
|
Return to Top |